Viewing Study NCT00126035



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126035
Status: COMPLETED
Last Update Posted: 2005-08-17
First Post: 2005-07-29

Brief Title: Study With Migraid Device in Acute Early Treatment of Migraine With Typical Aura
Sponsor: Profess Medical Consultancy
Organization: Profess Medical Consultancy

Study Overview

Official Title: Open Randomised Multi-Centre Cross-Over Study to Investigate the Efficacy of the Migraid Device Compared With No Device Treatment in the Acute Early Treatment of Migraine With Typical Aura
Status: COMPLETED
Status Verified Date: 2005-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study was to assess the efficacy of Migraid in terms of preventing headaches in patients with migraine with typical aura The secondary objectives were to assess whether Migraid is able to achieve pain relief andor relief of migraine associated symptoms and to evaluate the safety and tolerability of the study treatment
Detailed Description: Migraid is to be used only once during the aura phase of a migraine attack for a duration of 60 minutes

Reference therapy No treatment This means that at random the patient will be allocated to either of the two treatment orders the first treatment order is to use the Migraid whenever a migraine attack with an aura occurs During the next migraine attack the Migraid will not be used and vice versa for the other group of patients

Patients will be asked to complete diary cards to record details for each of the two migraine attacks and the severity of the migraine headache at certain points in time at t 30 minutes t 60 minutes t 90 minutes t 120 minutes t 150 minutes t 180 minutes and t 24 hours

Also associated symptoms will be asked for Rescue medication data including name time taken and amount will also be registered in the diary card

For all primary and secondary variables of efficacy the following definitions will be used

Grade or score Pain level Description

0 None - No pain

1 Mild - A headache with no remarkable pain that does not hinder you in performing your usual daily activities
2 Moderate - A headache with pain that hinders you in performing your usual daily activities but that does necessitate you to go to bed
3 Severe - A headache with pain that necessitates you to go to or stay in bed

The associated symptoms will be graded as either present or absent These symptoms are defined to conform to the following table

Symptom Description

Nausea Sick to the stomachfeel like throwing up Vomiting Throwing up or puking Photophobia Light bothers or hurts the eyes Phonophobia Noise bothers or hurts the ears

A migraine attack is defined as

New onset of migraine pain preceded by a pain-free period of at least 24-hours duration

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None